Tilray Inc (NASDAQ:TLRY - Get Free Report) shares dropped 2.4% on Thursday . The stock traded as low as $1.40 and last traded at $1.41. Approximately 6,376,600 shares were traded during trading, a decline of 75% from the average daily volume of 25,449,266 shares. The stock had previously closed at $1.44.
Wall Street Analyst Weigh In
Separately, Roth Mkm reduced their target price on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a report on Friday, October 11th.
Get Our Latest Stock Analysis on Tilray
Tilray Stock Performance
The stock has a market capitalization of $1.26 billion, a P/E ratio of -5.20 and a beta of 2.14. The stock has a 50 day simple moving average of $1.66 and a two-hundred day simple moving average of $1.78. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.04). The company had revenue of $200.00 million during the quarter, compared to analysts' expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The business's revenue was up 13.0% on a year-over-year basis. During the same period last year, the firm posted ($0.10) earnings per share. On average, equities analysts forecast that Tilray Inc will post -0.14 EPS for the current fiscal year.
Institutional Trading of Tilray
Hedge funds have recently added to or reduced their stakes in the company. Ferguson Wellman Capital Management Inc. acquired a new position in shares of Tilray during the 3rd quarter worth approximately $26,000. HBK Sorce Advisory LLC bought a new position in Tilray in the 1st quarter valued at approximately $37,000. Prospect Financial Services LLC bought a new position in shares of Tilray in the 2nd quarter valued at $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in shares of Tilray during the second quarter valued at about $29,000. Finally, Jeppson Wealth Management LLC bought a new stake in Tilray during the 2nd quarter worth approximately $33,000. 9.35% of the stock is owned by institutional investors and hedge funds.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
